Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.34 trillion and total revenue of $123.57 billion.
Market Cap
1.34T
Revenue
123.57B
Profits
-32.89B
PE Ratio
n/a
Profit Margin
-26.61%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 138.86B | -0.58% | 940,537 | 12.95B |
| 2 | MRNA | Moderna, Inc. | 101.38B | -6.86% | 11,097,710 | 2.53B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 91.92B | -0.43% | 508,577 | 16.90B |
| 4 | ARGX | argenx SE | 60.90B | 1.06% | 411,565 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 48.48B | 1.70% | 591,546 | 6.45B |
| 6 | RVMD | Revolution Medicines, Inc. | 41.77B | -3.52% | 2,062,173 | 197.56M |
| 7 | RPRX | Royalty Pharma plc | 39.84B | 1.00% | 3,389,080 | 2.62B |
| 8 | GMAB | Genmab A/S | 32.77B | -3.06% | 3,082,916 | 4.30B |
| 9 | ROIV | Roivant Sciences Ltd. | 29.83B | 1.23% | 9,741,101 | 41.08M |
| 10 | INSM | Insmed Incorporated | 26.22B | 2.94% | 2,942,548 | 1.52B |
| 11 | INCY | Incyte Corporation | 24.54B | -1.23% | 1,797,798 | 6.01B |
| 12 | BNTX | BioNTech SE | 21.63B | -0.32% | 693,309 | 2.75B |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.31B | -3.19% | 2,407,545 | 5.01B |
| 14 | EXEL | Exelixis, Inc. | 17.22B | -1.63% | 3,631,256 | 2.50B |
| 15 | ASND | Ascendis Pharma A/S | 16.82B | -1.46% | 829,553 | 1.20B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.75B | 0.77% | 576,684 | 4.72B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 15.31B | 0.87% | 3,284,439 | 945.54M |
| 18 | SMMT | Summit Therapeutics Inc. | 14.25B | -0.11% | 4,491,910 | - |
| 19 | HALO | Halozyme Therapeutics, Inc. | 11.75B | 0.11% | 2,045,239 | 1.80B |
| 20 | KYMR | Kymera Therapeutics, Inc. | 11.66B | -1.63% | 994,955 | 102.24M |
| 21 | TECH | Bio-Techne Corporation | 11.44B | -0.01% | 3,018,802 | 1.23B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 11.06B | -0.12% | 1,425,784 | 3.66B |
| 23 | PCVX | Vaxcyte, Inc. | 10.52B | -1.64% | 918,205 | - |
| 24 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.04B | -0.11% | 451,572 | 1.43B |
| 25 | SYRE | Spyre Therapeutics, Inc. | 9.92B | -4.17% | 1,003,961 | - |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.44B | 1.48% | 518,123 | 7.46M |
| 27 | TGTX | TG Therapeutics, Inc. | 9.11B | 1.37% | 5,788,580 | 897.76M |
| 28 | KRYS | Krystal Biotech, Inc. | 9.06B | 0.91% | 196,369 | 470.03M |
| 29 | PTGX | Protagonist Therapeutics, Inc. | 8.90B | 0.28% | 507,002 | 551.69M |
| 30 | TWST | Twist Bioscience Corporation | 8.29B | -2.33% | 1,475,787 | 431.80M |
| 31 | ABVX | ABIVAX Société Anonyme | 8.10B | 3.78% | 1,077,436 | 5.33M |
| 32 | CORT | Corcept Therapeutics Incorporated | 8.02B | -2.27% | 1,590,491 | 963.65M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.90B | 0.05% | 613,282 | 280.75M |
| 34 | CYTK | Cytokinetics, Incorporated | 7.83B | 1.96% | 2,357,482 | 113.29M |
| 35 | ORKA | Oruka Therapeutics, Inc. | 7.45B | 5.08% | 2,610,846 | - |
| 36 | AXSM | Axsome Therapeutics, Inc. | 7.41B | 5.17% | 1,282,809 | 865.27M |
| 37 | IMVT | Immunovant, Inc. | 7.39B | 1.59% | 1,330,889 | - |
| 38 | IBRX | ImmunityBio, Inc. | 7.18B | -5.13% | 18,728,620 | 182.57M |
| 39 | CAI | Caris Life Sciences, Inc. | 7.01B | -4.38% | 5,073,257 | 1.05B |
| 40 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.92B | -0.45% | 2,637,076 | 669.50M |
| 41 | KOD | Kodiak Sciences Inc. | 6.80B | 1.18% | 589,297 | - |
| 42 | CGON | CG Oncology, Inc. | 6.49B | -2.84% | 821,107 | 6.17M |
| 43 | BLTE | Belite Bio, Inc | 6.30B | -0.87% | 176,979 | - |
| 44 | LGND | Ligand Pharmaceuticals Incorporated | 6.29B | 0.06% | 168,917 | 253.83M |
| 45 | MANE | Veradermics, Incorporated | 6.19B | 3.00% | 598,827 | - |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 6.17B | 1.46% | 626,553 | 670.78M |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.85B | -6.83% | 2,060,942 | 570.00K |
| 48 | COGT | Cogent Biosciences, Inc. | 5.51B | -5.61% | 2,849,749 | - |
| 49 | ERAS | Erasca, Inc. | 5.42B | -0.70% | 5,984,545 | - |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.36B | -1.41% | 626,147 | 1.16B |
| 51 | EWTX | Edgewise Therapeutics, Inc. | 5.10B | -4.35% | 1,939,057 | - |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 5.04B | -0.59% | 493,434 | 2.72M |
| 53 | TVTX | Travere Therapeutics, Inc. | 4.99B | 0.68% | 1,094,256 | 651.03M |
| 54 | DFTX | Definium Therapeutics, Inc. | 4.74B | -2.18% | 1,295,028 | - |
| 55 | IONS | Ionis Pharmaceuticals, Inc. | 4.69B | -9.13% | 10,676,302 | 960.09M |
| 56 | RLAY | Relay Therapeutics, Inc. | 4.40B | -2.26% | 2,402,085 | 10.35M |
| 57 | CRSP | CRISPR Therapeutics AG | 4.39B | -9.65% | 4,003,926 | 25.17M |
| 58 | TNGX | Tango Therapeutics, Inc. | 4.12B | 6.82% | 4,070,912 | 53.81M |
| 59 | XENE | Xenon Pharmaceuticals Inc. | 4.07B | 2.40% | 2,087,455 | 7.50M |
| 60 | ABCL | AbCellera Biologics Inc. | 4.03B | -0.60% | 3,906,325 | 67.85M |
| 61 | LEGN | Legend Biotech Corporation | 3.95B | -16.06% | 6,377,406 | 1.36B |
| 62 | IRON | Disc Medicine, Inc. | 3.86B | 4.36% | 1,925,301 | - |
| 63 | ELVN | Enliven Therapeutics, Inc. | 3.77B | -0.56% | 950,991 | - |
| 64 | IOVA | Iovance Biotherapeutics, Inc. | 3.74B | -1.10% | 10,047,556 | 378.98M |
| 65 | PBLS | Parabilis Medicines, Inc. | 3.71B | -1.15% | 502,202 | 148.00K |
| 66 | VKTX | Viking Therapeutics, Inc. | 3.66B | -1.10% | 4,256,780 | - |
| 67 | TARS | Tarsus Pharmaceuticals, Inc. | 3.64B | 4.25% | 851,760 | 682.20M |
| 68 | VRDN | Viridian Therapeutics, Inc. | 3.50B | 2.15% | 2,713,842 | 26.31M |
| 69 | ARQT | Arcutis Biotherapeutics, Inc. | 3.47B | 4.73% | 1,955,845 | 508.68M |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.36B | -3.71% | 2,392,553 | - |
| 71 | CELC | Celcuity Inc. | 3.29B | -4.77% | 673,263 | - |
| 72 | DNLI | Denali Therapeutics Inc. | 3.18B | -2.39% | 975,838 | 21.38M |
| 73 | ACAD | Acadia Pharmaceuticals Inc. | 3.16B | 10.70% | 6,353,642 | 1.20B |
| 74 | TLX | Telix Pharmaceuticals Limited | 3.07B | -4.45% | 161,442 | 890.79M |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 3.07B | -0.97% | 950,297 | 36.54M |
| 76 | VCEL | Vericel Corporation | 3.01B | 1.09% | 1,331,065 | 324.17M |
| 77 | ZLAB | Zai Lab Limited | 2.97B | -1.68% | 1,501,668 | 441.73M |
| 78 | XNCR | Xencor, Inc. | 2.97B | 2.46% | 979,955 | 200.49M |
| 79 | ADMA | ADMA Biologics, Inc. | 2.81B | -1.09% | 3,311,183 | 519.15M |
| 80 | MBX | MBX Biosciences, Inc. | 2.80B | 4.42% | 1,123,594 | - |
| 81 | RCUS | Arcus Biosciences, Inc. | 2.69B | -1.48% | 1,152,273 | 100.00M |
| 82 | BEAM | Beam Therapeutics Inc. | 2.51B | -6.85% | 2,875,749 | 146.64M |
| 83 | SEPN | Septerna, Inc. | 2.48B | 2.90% | 476,771 | 96.27M |
| 84 | PVLA | Palvella Therapeutics, Inc. | 2.47B | -3.07% | 372,973 | - |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.41B | -1.82% | 820,481 | 158.00K |
| 86 | PHVS | Pharvaris N.V. | 2.39B | -1.32% | 662,569 | - |
| 87 | NAMS | NewAmsterdam Pharma Company N.V. | 2.30B | 0.95% | 2,361,710 | 25.94M |
| 88 | BHVN | Biohaven Ltd. | 2.28B | -0.72% | 1,777,208 | - |
| 89 | VIR | Vir Biotechnology, Inc. | 2.25B | -3.55% | 1,297,386 | 302.80M |
| 90 | ZYME | Zymeworks Inc. | 2.23B | 2.08% | 1,526,787 | 265.97M |
| 91 | RXRX | Recursion Pharmaceuticals, Inc. | 2.22B | -6.57% | 18,098,417 | 68.23M |
| 92 | REPL | Replimune Group, Inc. | 2.21B | 4.63% | 3,016,396 | - |
| 93 | IMNM | Immunome, Inc. | 2.20B | -3.67% | 1,253,488 | 4.02M |
| 94 | TRAX | First Tracks Biotherapeutics, Inc. | 2.20B | 5.17% | 1,150,314 | - |
| 95 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | -1.93% | 813,808 | 321.74M |
| 96 | VERA | Vera Therapeutics, Inc. | 2.17B | -1.76% | 1,851,785 | 10.28M |
| 97 | TRVI | Trevi Therapeutics, Inc. | 2.13B | -2.58% | 2,322,304 | - |
| 98 | LKFT | Lakefront Biotherapeutics NV | 2.10B | -0.33% | 228,621 | 1.13B |
| 99 | FTRE | Fortrea Holdings Inc. | 2.06B | -3.87% | 935,088 | 2.67B |
| 100 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.04B | -2.00% | 1,745,222 | 213.00M |
| 101 | HRMY | Harmony Biosciences Holdings, Inc. | 1.97B | -0.65% | 1,326,800 | 989.36M |
| 102 | ZBIO | Zenas BioPharma, Inc. | 1.94B | 0.23% | 270,260 | 11.00M |
| 103 | MAZE | Maze Therapeutics, Inc. | 1.91B | 1.55% | 1,136,173 | 20.00M |
| 104 | AGIO | Agios Pharmaceuticals, Inc. | 1.90B | 1.18% | 1,005,362 | 140.84M |
| 105 | KLRA | Kailera Therapeutics, Inc. | 1.85B | 4.01% | 1,182,540 | - |
| 106 | COAG | Hemab Therapeutics Holdings, Inc. | 1.82B | -9.23% | 817,047 | - |
| 107 | MESO | Mesoblast Limited | 1.79B | -3.08% | 90,245 | 120.25M |
| 108 | LYCA | Lycia Therapeutics, Inc. | 1.79B | 2.11% | 239,448 | 4.44M |
| 109 | STOK | Stoke Therapeutics, Inc. | 1.78B | -1.77% | 838,275 | 28.21M |
| 110 | GENB | Generate Biomedicines, Inc. | 1.77B | -2.82% | 529,660 | 26.48M |
| 111 | SRPT | Sarepta Therapeutics, Inc. | 1.76B | -4.87% | 3,309,139 | 1.96B |
| 112 | NRIX | Nurix Therapeutics, Inc. | 1.73B | -1.67% | 2,582,658 | 701.94M |
| 113 | ABSI | Absci Corporation | 1.71B | -7.78% | 4,100,105 | 1.56M |
| 114 | SLS | SELLAS Life Sciences Group, Inc. | 1.69B | -2.56% | 3,881,121 | - |
| 115 | NVAX | Novavax, Inc. | 1.68B | -6.47% | 8,511,858 | 411.65M |
| 116 | IMCR | Immunocore Holdings plc | 1.68B | 2.17% | 791,962 | 429.30M |
| 117 | NBTX | Nanobiotix S.A. | 1.66B | 2.44% | 49,711 | 13.15M |
| 118 | RARE | Ultragenyx Pharmaceutical Inc. | 1.64B | -1.74% | 5,464,307 | 730.00M |
| 119 | PGEN | Precigen, Inc. | 1.62B | -4.76% | 6,026,139 | 156.94M |
| 120 | BRVE | Braveheart Bio, Inc. | 1.60B | 0.72% | 211,466 | - |
| 121 | QURE | uniQure N.V. | 1.59B | -0.48% | 1,137,482 | 20.17M |
| 122 | NTLA | Intellia Therapeutics, Inc. | 1.57B | -7.84% | 4,180,130 | 52.89M |
| 123 | GPCR | Structure Therapeutics Inc. | 1.55B | 1.54% | 1,441,651 | - |
| 124 | RAPP | Rapport Therapeutics, Inc. | 1.54B | -0.46% | 660,122 | 20.00M |
| 125 | ADRX | ADARx Pharmaceuticals, Inc. | 1.52B | -1.81% | 289,825 | 6.13M |
| 126 | DMRA | Damora Therapeutics, Inc. | 1.49B | 0.29% | 466,095 | - |
| 127 | NUVB | Nuvation Bio Inc. | 1.48B | -3.33% | 3,478,343 | 201.73M |
| 128 | OCUL | Ocular Therapeutix, Inc. | 1.45B | -3.58% | 2,657,527 | 50.38M |
| 129 | LBRX | LB Pharmaceuticals Inc | 1.45B | -0.55% | 377,881 | - |
| 130 | TYRA | Tyra Biosciences, Inc. | 1.45B | -5.74% | 793,825 | - |
| 131 | ANAB | AnaptysBio, Inc. | 1.45B | 0.77% | 244,924 | 106.09M |
| 132 | KARD | Kardigan, Inc. | 1.42B | 0.20% | 709,337 | - |
| 133 | AAPG | Ascentage Pharma Group International | 1.42B | 0.91% | 1,347 | 94.61M |
| 134 | KRSA | Korsana Biosciences, Inc. | 1.41B | -0.71% | 383,987 | - |
| 135 | TSHA | Taysha Gene Therapies, Inc. | 1.39B | -2.17% | 2,081,005 | 5.49M |
| 136 | AVLN | Avalyn Pharma Inc. | 1.38B | 5.69% | 478,189 | - |
| 137 | MLYS | Mineralys Therapeutics, Inc. | 1.38B | -1.68% | 1,717,837 | - |
| 138 | MNKD | MannKind Corporation | 1.36B | 1.19% | 4,113,116 | 413.37M |
| 139 | INVA | Innoviva, Inc. | 1.36B | 0.42% | 785,945 | 438.32M |
| 140 | INBX | Inhibrx Biosciences, Inc. | 1.35B | -0.37% | 100,294 | 1.30M |
| 141 | GHRS | GH Research PLC | 1.34B | 1.14% | 108,738 | - |
| 142 | SVRA | Savara Inc. | 1.32B | -2.57% | 1,727,144 | - |
| 143 | NKTR | Nektar Therapeutics | 1.29B | 0.17% | 420,205 | 54.59M |
| 144 | DRTS | Alpha Tau Medical Ltd. | 1.26B | -2.91% | 426,928 | - |
| 145 | OMER | Omeros Corporation | 1.25B | -1.57% | 683,168 | 38.42M |
| 146 | URGN | UroGen Pharma Ltd. | 1.24B | -3.69% | 721,796 | 250.25M |
| 147 | SLN | Silence Therapeutics plc | 1.23B | 0.20% | 827,868 | 615.00K |
| 148 | VOR | Vor Biopharma Inc. | 1.20B | -2.05% | 405,778 | - |
| 149 | SPTX | Seaport Therapeutics, Inc. | 1.18B | 0.34% | 301,047 | - |
| 150 | SGP | SpyGlass Pharma, Inc. | 1.16B | -9.49% | 82,462 | - |
| 151 | ANRO | Alto Neuroscience, Inc. | 1.11B | 1.37% | 515,786 | - |
| 152 | VSTM | Verastem, Inc. | 1.10B | 0.34% | 2,952,427 | 100.30M |
| 153 | MLTX | MoonLake Immunotherapeutics | 1.07B | -0.40% | 903,632 | - |
| 154 | JBIO | Jade Biosciences, Inc. | 1.04B | 5.32% | 893,617 | - |
| 155 | CTY | City Therapeutics, Inc. | 975.23M | 4.98% | 419,064 | 14.34M |
| 156 | AKTS | Aktis Oncology, Inc. | 973.34M | 6.90% | 463,607 | 10.06M |
| 157 | ODTX | Odyssey Therapeutics, Inc. | 967.93M | 5.43% | 352,646 | 99.00K |
| 158 | CRVS | Corvus Pharmaceuticals, Inc. | 959.10M | 0.18% | 950,674 | - |
| 159 | MGTX | MeiraGTx Holdings plc | 923.93M | 1.37% | 774,631 | 397.50M |
| 160 | ORIC | ORIC Pharmaceuticals, Inc. | 921.47M | -3.68% | 1,010,974 | - |
| 161 | IVA | Inventiva S.A. | 911.77M | 2.99% | 2,215,846 | 2.81M |
| 162 | PHAR | Pharming Group N.V. | 903.22M | -1.98% | 7,101 | 386.75M |
| 163 | GLUE | Monte Rosa Therapeutics, Inc. | 896.37M | -0.85% | 1,496,061 | 70.33M |
| 164 | LTGO | Latigo Biotherapeutics, Inc. | 882.44M | -0.30% | 780,386 | - |
| 165 | IMTX | Immatics N.V. | 878.23M | -0.08% | 1,219,918 | 49.33M |
| 166 | BBTX | Bambusa Therapeutics, Inc. | 871.12M | 0.94% | 134,296 | - |
| 167 | SNDX | Syndax Pharmaceuticals, Inc. | 851.67M | -0.94% | 2,925,886 | 289.68M |
| 168 | OBX | Obsidian Therapeutics, Inc. | 846.29M | -0.07% | 743,896 | - |
| 169 | LXRX | Lexicon Pharmaceuticals, Inc. | 834.81M | 3.02% | 3,404,409 | 38.54M |
| 170 | RIGL | Rigel Pharmaceuticals, Inc. | 828.52M | 4.64% | 169,893 | 288.21M |
| 171 | ALMS | Alumis Inc. | 827.74M | -2.37% | 1,540,616 | 7.40M |
| 172 | DNA | Ginkgo Bioworks Holdings, Inc. | 808.76M | -2.91% | 1,469,297 | 130.75M |
| 173 | ANNX | Annexon, Inc. | 802.16M | -0.59% | 4,594,596 | - |
| 174 | SLDB | Solid Biosciences Inc. | 801.92M | 2.35% | 1,709,441 | - |
| 175 | AURA | Aura Biosciences, Inc. | 797.21M | - | 875,166 | - |
| 176 | SGMT | Sagimet Biosciences Inc. | 771.49M | 0.46% | 1,573,137 | - |
| 177 | ABUS | Arbutus Biopharma Corporation | 755.78M | 2.69% | 2,287,394 | 181.49M |
| 178 | ATTO | Attovia Therapeutics, Inc. | 755.07M | 3.63% | 185,484 | 1.44M |
| 179 | ARDX | Ardelyx, Inc. | 754.12M | 2.39% | 5,465,941 | 468.22M |
| 180 | OABI | OmniAb, Inc. | 744.62M | -3.68% | 1,752,639 | 40.21M |
| 181 | JANX | Janux Therapeutics, Inc. | 736.65M | -5.64% | 2,354,404 | 23.29M |
| 182 | DBVT | DBV Technologies S.A. | 734.63M | 4.52% | 162,612 | 3.74M |
| 183 | NVCT | Nuvectis Pharma, Inc. | 726.98M | 0.57% | 201,654 | - |
| 184 | SANA | Sana Biotechnology, Inc. | 726.61M | -1.62% | 2,533,400 | - |
| 185 | CGEM | Cullinan Therapeutics, Inc. | 720.77M | -4.52% | 810,346 | - |
| 186 | CADL | Candel Therapeutics, Inc. | 715.45M | -1.48% | 620,994 | - |
| 187 | ZVRA | Zevra Therapeutics, Inc. | 709.89M | -1.73% | 1,063,464 | 147.76M |
| 188 | AVBP | ArriVent BioPharma, Inc. | 698.26M | -4.66% | 665,991 | 5.00M |
| 189 | IAM | Iambic Therapeutics, Inc. | 696.32M | 9.79% | 854,948 | 18.25M |
| 190 | IMMX | Immix Biopharma, Inc. | 693.07M | -2.45% | 825,379 | - |
| 191 | PRME | Prime Medicine, Inc. | 692.05M | -9.53% | 4,327,081 | 4.07M |
| 192 | CLYM | Climb Bio, Inc. | 689.00M | 6.54% | 1,567,023 | - |
| 193 | FDMT | 4D Molecular Therapeutics, Inc. | 687.79M | -0.24% | 1,075,496 | 92.01M |
| 194 | DSGN | Design Therapeutics, Inc. | 681.03M | -1.53% | 264,893 | - |
| 195 | BCAX | Bicara Therapeutics Inc. | 676.49M | 2.10% | 1,950,780 | - |
| 196 | KURA | Kura Oncology, Inc. | 672.54M | -0.13% | 2,463,786 | 77.23M |
| 197 | WVE | Wave Life Sciences, Inc. | 671.56M | -2.16% | 1,400,014 | 70.92M |
| 198 | HELP | Helus Pharma Inc. | 663.39M | -3.09% | 1,140,946 | - |
| 199 | APMD | Apnimed, Inc. | 659.22M | 0.16% | 378,259 | 115.12M |
| 200 | ACRS | Aclaris Therapeutics, Inc. | 659.03M | -2.00% | 1,397,401 | 6.40M |
| 201 | ANL | Adlai Nortye Group Ltd. | 639.79M | -10.90% | 377,005 | 18.06M |
| 202 | OLMA | Olema Pharmaceuticals, Inc. | 635.23M | -1.36% | 935,186 | - |
| 203 | GERN | Geron Corporation | 624.07M | -2.79% | 12,498,825 | 217.52M |
| 204 | CBIO | Crescent Biopharma, Inc. | 592.79M | 1.47% | 168,277 | 11.88M |
| 205 | SRZN | Surrozen, Inc. | 584.16M | 4.34% | 173,146 | 10.53M |
| 206 | VALN | Valneva SE | 574.93M | 4.59% | 24,426 | 163.30M |
| 207 | ENTX | Entera Bio Ltd. | 558.29M | -1.23% | 98,553 | 42.00K |
| 208 | OVID | Ovid Therapeutics Inc. | 545.86M | -1.93% | 2,307,540 | 1.45M |
| 209 | NGNE | Neurogene Inc. | 523.11M | -2.81% | 344,516 | 925.00K |
| 210 | DMAC | DiaMedica Therapeutics Inc. | 522.54M | 0.41% | 144,931 | - |
| 211 | CAPR | Capricor Therapeutics, Inc. | 515.69M | -9.95% | 4,397,177 | 11.13M |
| 212 | SLBT | SL Science Holding Limited | 513.24M | -8.01% | 21,666 | 3.27M |
| 213 | RGNX | REGENXBIO Inc. | 508.15M | -4.77% | 1,084,411 | 153.91M |
| 214 | EPRX | Eupraxia Pharmaceuticals Inc. | 503.11M | 3.10% | 475,800 | - |
| 215 | ETRA | Electra Therapeutics, Inc. | 499.62M | -3.16% | 298,181 | - |
| 216 | STTK | Shattuck Labs, Inc. | 493.94M | -2.81% | 734,950 | 1.00M |
| 217 | MDXG | MiMedx Group, Inc. | 491.77M | 1.51% | 851,322 | 303.73M |
| 218 | MNPR | Monopar Therapeutics Inc. | 480.39M | -2.96% | 88,064 | - |
| 219 | OCS | Oculis Holding AG | 469.16M | -2.06% | 266,841 | 1.12M |
| 220 | GYRE | Gyre Therapeutics, Inc. | 461.89M | -9.25% | 113,350 | 110.06M |
| 221 | RLMD | Relmada Therapeutics, Inc. | 455.48M | 3.14% | 985,677 | - |
| 222 | BLSM | BlossomHill Therapeutics, Inc. | 454.37M | -1.14% | 175,882 | - |
| 223 | ARVN | Arvinas, Inc. | 452.17M | 2.14% | 702,504 | 275.30M |
| 224 | OBIO | Orchestra BioMed Holdings, Inc. | 450.97M | 0.53% | 485,530 | 31.98M |
| 225 | INDP | Indaptus Therapeutics, Inc. | 443.08M | -7.83% | 474,950 | - |
| 226 | PRTA | Prothena Corporation plc | 439.04M | -2.56% | 394,123 | 52.74M |
| 227 | CTMX | CytomX Therapeutics, Inc. | 434.92M | 0.76% | 16,647,535 | 14.03M |
| 228 | ASMB | Assembly Biosciences, Inc. | 434.70M | -2.02% | 263,292 | 74.85M |
| 229 | PHAT | Phathom Pharmaceuticals, Inc. | 432.50M | 2.16% | 1,505,095 | 274.88M |
| 230 | TECX | Tectonic Therapeutic, Inc. | 431.06M | 0.73% | 192,783 | - |
| 231 | YDES | YD Bio Limited | 426.40M | -10.28% | 103,560 | 1.24M |
| 232 | RZLT | Rezolute, Inc. | 421.19M | 3.75% | 1,475,165 | - |
| 233 | PBYI | Puma Biotechnology, Inc. | 419.79M | -3.28% | 602,370 | 231.87M |
| 234 | CRMD | CorMedix Inc. | 417.78M | -2.01% | 2,325,304 | 462.25M |
| 235 | MPLT | MapLight Therapeutics, Inc. | 414.59M | 2.47% | 458,115 | - |
| 236 | CTNM | Contineum Therapeutics, Inc. | 414.45M | 2.48% | 249,721 | - |
| 237 | AVTX | Avalo Therapeutics, Inc. | 414.30M | -1.44% | 3,895,508 | 59.00K |
| 238 | LYEL | Lyell Immunopharma, Inc. | 410.58M | 8.30% | 228,082 | 15.00K |
| 239 | CCCC | C4 Therapeutics, Inc. | 393.95M | -4.76% | 1,453,490 | 32.28M |
| 240 | PRLD | Prelude Therapeutics Incorporated | 389.32M | 0.53% | 388,389 | 22.42M |
| 241 | EDIT | Editas Medicine, Inc. | 386.62M | -8.91% | 1,577,295 | 49.83M |
| 242 | ASPE | Aspen Neuroscience, Inc. | 378.02M | 4.84% | 279,267 | - |
| 243 | ALEC | Alector, Inc. | 376.66M | 2.85% | 3,253,710 | 173.47M |
| 244 | ALT | Altimmune, Inc. | 376.39M | -8.73% | 3,983,149 | 31.00K |
| 245 | FENC | Fennec Pharmaceuticals Inc. | 371.71M | -2.12% | 228,386 | 59.22M |
| 246 | DTIL | Precision BioSciences, Inc. | 363.20M | -1.70% | 352,757 | 45.04M |
| 247 | SPRY | ARS Pharmaceuticals, Inc. | 358.38M | 13.17% | 2,903,270 | 122.14M |
| 248 | IRD | Opus Genetics, Inc. | 352.75M | 0.95% | 1,069,615 | 7.91M |
| 249 | TRXB | TRex Bio, Inc. | 351.33M | -3.97% | 82,507 | - |
| 250 | AUTL | Autolus Therapeutics plc | 346.01M | -1.52% | 7,215,329 | 137.43M |
| 251 | AGMB | AgomAb Therapeutics NV | 343.01M | -7.75% | 447,059 | - |
| 252 | GALT | Galectin Therapeutics Inc. | 341.88M | -2.02% | 167,268 | - |
| 253 | PROK | ProKidney Corp. | 338.60M | -2.61% | 651,105 | 818.00K |
| 254 | AVIR | Atea Pharmaceuticals, Inc. | 336.07M | -5.10% | 301,493 | - |
| 255 | FTH | Faeth Therapeutics, Inc. | 334.38M | 2.05% | 1,384,057 | - |
| 256 | EIKN | Eikon Therapeutics, Inc. | 332.03M | 4.43% | 424,889 | - |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 331.36M | -2.55% | 467,505 | 16.96M |
| 258 | SCTX | Scribe Therapeutics Inc. | 331.12M | 4.86% | 342,280 | 33.30M |
| 259 | ENTA | Enanta Pharmaceuticals, Inc. | 327.37M | -2.01% | 353,599 | 65.26M |
| 260 | BNTC | Benitec Biopharma Inc. | 325.11M | -5.57% | 105,713 | - |
| 261 | ALLO | Allogene Therapeutics, Inc. | 323.18M | -12.00% | 22,849,424 | 4.64M |
| 262 | OCGN | Ocugen, Inc. | 320.48M | -2.84% | 6,785,170 | 4.78M |
| 263 | PEPG | PepGen Inc. | 319.29M | 92.89% | 104,894,037 | - |
| 264 | AGEN | Agenus Inc. | 317.40M | -1.89% | 691,264 | 133.95M |
| 265 | KYTX | Kyverna Therapeutics, Inc. | 314.47M | -1.64% | 472,217 | - |
| 266 | CABA | Cabaletta Bio, Inc. | 313.87M | -3.00% | 3,594,779 | - |
| 267 | VCRE | Vicore Pharma Holding AB (publ) | 313.20M | 0.27% | 24,639 | 383.48K |
| 268 | IPSC | Century Therapeutics, Inc. | 304.21M | -7.18% | 720,025 | 109.16M |
| 269 | TTRX | Turn Therapeutics Inc. | 295.20M | 1.23% | 88,089 | - |
| 270 | NAUT | Nautilus Biotechnology, Inc. | 293.59M | -3.15% | 2,901,884 | 424.00K |
| 271 | EVMN | Evommune, Inc. | 285.26M | 2.75% | 843,158 | 10.00M |
| 272 | IKT | Inhibikase Therapeutics, Inc. | 284.95M | -6.85% | 483,650 | 1.00 |
| 273 | FULC | Fulcrum Therapeutics, Inc. | 283.44M | -0.13% | 932,214 | 80.00M |
| 274 | LRMR | Larimar Therapeutics, Inc. | 280.27M | 6.13% | 736,595 | - |
| 275 | QTTB | Q32 Bio Inc. | 278.89M | -0.21% | 324,021 | 53.74M |
| 276 | SABS | SAB Biotherapeutics, Inc. | 276.57M | -0.97% | 676,897 | 114.70K |
| 277 | VOGX | Vogenx, Inc. | 274.82M | 0.87% | 113,976 | - |
| 278 | ARCT | Arcturus Therapeutics Holdings Inc. | 270.93M | -0.95% | 851,505 | 30.51M |
| 279 | CAMP | Camp4 Therapeutics Corporation | 269.84M | -8.32% | 109,020 | 5.32M |
| 280 | RCKT | Rocket Pharmaceuticals, Inc. | 269.50M | -2.96% | 1,224,136 | - |
| 281 | INO | Inovio Pharmaceuticals, Inc. | 264.08M | -2.65% | 13,718,863 | 65.34K |
| 282 | LCTX | Lineage Cell Therapeutics, Inc. | 263.02M | -3.70% | 1,147,470 | 13.08M |
| 283 | VTVT | vTv Therapeutics Inc. | 260.92M | -0.85% | 24,683 | 36.84M |
| 284 | BCYC | Bicycle Therapeutics plc | 257.95M | -2.39% | 234,731 | 83.53M |
| 285 | CUVL | Clinuvel Pharmaceuticals Limited | 254.77M | -0.58% | 9,121 | 65.05M |
| 286 | LXEO | Lexeo Therapeutics, Inc. | 251.05M | -2.55% | 1,008,282 | - |
| 287 | IMRX | Immuneering Corporation | 249.99M | 5.75% | 769,326 | - |
| 288 | VNDA | Vanda Pharmaceuticals Inc. | 246.11M | -0.49% | 1,380,864 | 229.28M |
| 289 | GLSI | Greenwich LifeSciences, Inc. | 235.73M | -2.78% | 76,421 | - |
| 290 | PLX | Protalix BioTherapeutics, Inc. | 230.43M | 11.28% | 3,037,002 | 84.69M |
| 291 | ACIU | AC Immune SA | 228.18M | -5.94% | 144,157 | 23.75M |
| 292 | ELDN | Eledon Pharmaceuticals, Inc. | 225.32M | -3.48% | 680,133 | - |
| 293 | KRRO | Korro Bio, Inc. | 216.04M | 5.21% | 199,159 | 1.29M |
| 294 | FATE | Fate Therapeutics, Inc. | 212.68M | -8.51% | 1,668,125 | 4.75M |
| 295 | RNAC | Cartesian Therapeutics, Inc. | 210.47M | -1.71% | 93,438 | 1.03M |
| 296 | MDWD | MediWound Ltd. | 203.78M | 1.28% | 175,269 | 11.86M |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 201.35M | -0.39% | 9,808 | 1.80M |
| 298 | ARTV | Artiva Biotherapeutics, Inc. | 200.45M | -3.91% | 925,835 | 251.00K |
| 299 | CGEN | Compugen Ltd. | 197.97M | -2.34% | 214,834 | 75.93M |
| 300 | PALI | Palisade Bio, Inc. | 197.80M | -4.62% | 1,440,910 | 500.00K |
| 301 | PYXS | Pyxis Oncology, Inc. | 194.12M | -4.41% | 592,049 | 11.04M |
| 302 | TRDA | Entrada Therapeutics, Inc. | 191.84M | 12.05% | 577,868 | 3.98M |
| 303 | ACOG | Alpha Cognition Inc. | 188.81M | -2.58% | 107,835 | 15.26M |
| 304 | PRQR | ProQR Therapeutics N.V. | 184.87M | -5.07% | 247,762 | 21.05M |
| 305 | UPB | Upstream Bio, Inc. | 184.30M | -6.01% | 1,175,023 | 2.87M |
| 306 | KROS | Keros Therapeutics, Inc. | 183.29M | 1.85% | 274,345 | 40.76M |
| 307 | WHWK | Whitehawk Therapeutics, Inc. | 182.34M | -4.04% | 292,945 | 7.15M |
| 308 | IFRX | InflaRx N.V. | 179.79M | -6.87% | 283,212 | -38.53K |
| 309 | ZNTL | Zentalis Pharmaceuticals, Inc. | 177.86M | 4.02% | 2,397,556 | 26.87M |
| 310 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 176.38M | -4.35% | 486,286 | - |
| 311 | DRUG | Bright Minds Biosciences Inc. | 172.50M | -5.89% | 162,232 | - |
| 312 | IVVD | Invivyd, Inc. | 169.52M | -3.54% | 2,678,943 | 58.37M |
| 313 | STRO | Sutro Biopharma, Inc. | 168.80M | -4.05% | 217,226 | 45.70M |
| 314 | SION | Sionna Therapeutics, Inc. | 167.74M | 3.92% | 810,444 | - |
| 315 | ORMP | Oramed Pharmaceuticals Inc. | 165.14M | -0.75% | 80,562 | 2.00M |
| 316 | ANTX | AN2 Therapeutics, Inc. | 164.30M | 8.25% | 271,556 | - |
| 317 | HUMA | Humacyte, Inc. | 163.40M | 29.22% | 15,596,620 | 2.12M |
| 318 | VRXA | Veraxa Biotech AG | 155.55M | 8.91% | 163,791 | 29.54K |
| 319 | ALXO | ALX Oncology Holdings Inc. | 154.18M | -13.23% | 529,306 | - |
| 320 | MGNX | MacroGenics, Inc. | 153.84M | 3.21% | 467,982 | 175.14M |
| 321 | MSLE | Satellos Bioscience Inc. | 153.23M | -2.27% | 10,463 | - |
| 322 | TARA | Protara Therapeutics, Inc. | 150.85M | -2.39% | 460,622 | - |
| 323 | CMPX | Compass Therapeutics, Inc. | 150.82M | 0.07% | 2,113,855 | 850.00K |
| 324 | CNTN | Canton Strategic Holdings, Inc. | 149.00M | -3.11% | 612,500 | 1.50M |
| 325 | YARW | Yarrow Bioscience, Inc. | 145.80M | -0.76% | 92,025 | - |
| 326 | NGEN | NervGen Pharma Corp. | 143.01M | -4.66% | 263,745 | - |
| 327 | IPHA | Innate Pharma S.A. | 140.65M | 1.98% | 11,037 | 11.21M |
| 328 | ABEO | Abeona Therapeutics Inc. | 140.39M | -3.35% | 3,636,952 | 39.01M |
| 329 | CUE | Cue Biopharma, Inc. | 139.99M | -4.32% | 132,848 | 37.66M |
| 330 | RNA | Atrium Therapeutics, Inc. | 139.92M | -2.39% | 108,814 | 35.84M |
| 331 | ARMP | Armata Pharmaceuticals, Inc. | 139.80M | -1.05% | 63,717 | 5.54M |
| 332 | ADAG | Adagene Inc. | 137.64M | -3.30% | 85,678 | 9.29M |
| 333 | OKUR | OnKure Therapeutics, Inc. | 137.31M | 6.27% | 281,838 | - |
| 334 | ZURA | Zura Bio Limited | 135.34M | 13.31% | 16,936,950 | - |
| 335 | MENS | Jyong Biotech Ltd. | 135.10M | -1.62% | 15,940 | - |
| 336 | SPRB | Spruce Biosciences, Inc. | 129.91M | -8.39% | 72,392 | 697.00K |
| 337 | LENZ | LENZ Therapeutics, Inc. | 128.67M | -4.55% | 928,169 | 12.36M |
| 338 | PYPD | PolyPid Ltd. | 126.34M | -0.32% | 147,406 | - |
| 339 | NERV | Minerva Neurosciences, Inc. | 123.09M | -6.08% | 110,856 | - |
| 340 | MOLN | Molecular Partners AG | 119.67M | - | 346 | 856.30K |
| 341 | EQ | Equillium, Inc. | 114.41M | -2.67% | 157,297 | 4.39M |
| 342 | FHTX | Foghorn Therapeutics Inc. | 113.93M | -6.86% | 719,273 | 112.13M |
| 343 | VYGR | Voyager Therapeutics, Inc. | 113.57M | -8.29% | 647,440 | 25.11M |
| 344 | ENGN | enGene Therapeutics Inc. | 112.25M | -5.37% | 741,183 | - |
| 345 | OTLK | Outlook Therapeutics, Inc. | 112.11M | 0.26% | 1,049,975 | -1.16M |
| 346 | IMUX | Immunic, Inc. | 110.38M | 1.63% | 198,029 | - |
| 347 | CDXS | Codexis, Inc. | 110.05M | -9.46% | 634,641 | 77.68M |
| 348 | NTHI | NeOnc Technologies Holdings, Inc. | 106.88M | 14.97% | 379,584 | 39.99K |
| 349 | ANIX | Anixa Biosciences, Inc. | 106.72M | -2.85% | 146,118 | - |
| 350 | AVXL | Anavex Life Sciences Corp. | 104.75M | -7.38% | 582,758 | - |
| 351 | VANI | Vivani Medical, Inc. | 103.73M | 2.22% | 170,189 | - |
| 352 | UNCY | Unicycive Therapeutics, Inc. | 101.81M | -1.22% | 639,316 | - |
| 353 | NRXP | NRx Pharmaceuticals, Inc. | 101.67M | -1.26% | 491,508 | 3.39M |
| 354 | KZIA | Kazia Therapeutics Limited | 101.41M | -0.13% | 130,854 | 1.27M |
| 355 | NBP | NovaBridge Biosciences | 100.49M | -4.68% | 436,554 | - |
| 356 | CHRS | Coherus Oncology, Inc. | 99.04M | -21.61% | 4,729,370 | 53.64M |
| 357 | RTSN | Retension Pharmaceuticals, Inc. | 98.81M | -4.28% | 248,149 | - |
| 358 | NKTX | Nkarta, Inc. | 97.52M | -14.47% | 1,156,949 | - |
| 359 | HURA | TuHURA Biosciences, Inc. | 96.86M | -8.43% | 453,391 | - |
| 360 | MIST | Milestone Pharmaceuticals Inc. | 96.69M | -7.02% | 1,510,669 | 2.34M |
| 361 | PLYX | Polaryx Therapeutics, Inc. | 93.21M | -3.61% | 14,724 | - |
| 362 | ICCC | ImmuCell Corporation | 93.18M | 0.39% | 2,767 | 30.68M |
| 363 | PMVP | PMV Pharmaceuticals, Inc. | 91.75M | -2.80% | 584,778 | - |
| 364 | BDTX | Black Diamond Therapeutics, Inc. | 91.64M | -14.25% | 1,384,890 | 70.00M |
| 365 | CBUS | Cibus, Inc. | 90.57M | 3.04% | 177,132 | 4.35M |
| 366 | TENX | Tenax Therapeutics, Inc. | 90.33M | -5.34% | 1,107,716 | - |
| 367 | TVGN | Tevogen Inc. | 90.01M | -2.05% | 1,558 | - |
| 368 | SEER | Seer, Inc. | 89.15M | -4.17% | 118,511 | 14.22M |
| 369 | CLLS | Cellectis S.A. | 88.66M | 3.57% | 4,216 | 63.82M |
| 370 | GNLX | Genelux Corporation | 87.83M | -5.31% | 93,134 | 8.00K |
| 371 | NMRA | Neumora Therapeutics, Inc. | 85.30M | -6.57% | 741,855 | - |
| 372 | RLYB | Rallybio Corporation | 84.85M | -2.43% | 18,923 | 434.00K |
| 373 | TNYA | Tenaya Therapeutics, Inc. | 83.17M | -5.86% | 2,167,061 | 3.03M |
| 374 | ATRA | Atara Biotherapeutics, Inc. | 82.21M | 0.12% | 33,085 | 6.19M |
| 375 | TNXP | Tonix Pharmaceuticals Holding Corp. | 79.96M | -8.35% | 1,006,053 | 43.05M |
| 376 | NRXS | NeurAxis, Inc. | 79.87M | -3.78% | 76,520 | 6.53M |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 78.47M | -1.99% | 521,276 | 6.58M |
| 378 | TLSA | Tiziana Life Sciences Ltd | 78.26M | -8.64% | 392,767 | - |
| 379 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 76.20M | 11.93% | 642,800 | - |
| 380 | COYA | Coya Therapeutics, Inc. | 74.95M | -4.05% | 112,623 | 8.02M |
| 381 | PDSB | PDS Biotechnology Corporation | 74.29M | -5.09% | 4,211,709 | - |
| 382 | OKYO | OKYO Pharma Limited | 72.95M | 8.59% | 94,244 | - |
| 383 | HRTX | Heron Therapeutics, Inc. | 71.39M | 1.24% | 11,007,924 | 148.22M |
| 384 | NTRB | Nutriband Inc. | 69.59M | -3.94% | 6,906 | 1.62M |
| 385 | MNOV | MediciNova, Inc. | 69.40M | -4.08% | 65,000 | 920.48K |
| 386 | GOSS | Gossamer Bio, Inc. | 68.50M | 5.21% | 91,403 | 53.29M |
| 387 | CNXU | Conexeu Sciences Inc. | 67.21M | -6.44% | 202,125 | - |
| 388 | ACRV | Acrivon Therapeutics, Inc. | 66.85M | -1.27% | 75,138 | - |
| 389 | CING | Cingulate Inc. | 66.46M | 2.70% | 195,376 | - |
| 390 | CSBR | Champions Oncology, Inc. | 66.11M | -1.86% | 8,594 | 60.66M |
| 391 | MAIA | MAIA Biotechnology, Inc. | 64.78M | -2.29% | 250,937 | - |
| 392 | CGTX | Cognition Therapeutics, Inc. | 64.66M | -1.53% | 364,996 | - |
| 393 | FBIO | Fortress Biotech, Inc. | 63.70M | -4.02% | 178,661 | 68.47M |
| 394 | CLNN | Clene Inc. | 63.11M | 1.37% | 145,293 | 238.00K |
| 395 | CRDF | Cardiff Oncology, Inc. | 61.48M | -1.30% | 158,690 | 508.00K |
| 396 | VRCA | Verrica Pharmaceuticals Inc. | 60.47M | -1.95% | 7,875 | 30.32M |
| 397 | XBIT | XBiotech Inc. | 60.06M | 3.14% | 57,456 | - |
| 398 | SPRO | Spero Therapeutics, Inc. | 59.11M | -5.14% | 183,742 | 47.00M |
| 399 | XLO | Xilio Therapeutics, Inc. | 57.91M | -2.22% | 3,078 | 64.09M |
| 400 | NORD | Nordicus Partners Corporation | 56.76M | -17.33% | 9,017 | - |
| 401 | BOLD | Boundless Bio, Inc. | 54.82M | -2.03% | 118,646 | - |
| 402 | ANVS | Annovis Bio, Inc. | 53.93M | -3.52% | 1,640,781 | - |
| 403 | RNXT | RenovoRx, Inc. | 53.25M | - | 251,129 | 2.78M |
| 404 | ALPS | Alps Group Inc | 53.25M | -3.03% | 25,290 | 3.74M |
| 405 | ELOX | Eloxx Pharmaceuticals, Inc. | 52.76M | -3.26% | 18,062 | - |
| 406 | INKT | MiNK Therapeutics, Inc. | 51.08M | -2.77% | 4,415 | - |
| 407 | RNTX | Rein Therapeutics Inc. | 50.91M | -4.94% | 527,915 | - |
| 408 | IBIO | iBio, Inc. | 50.20M | -1.81% | 217,346 | 100.00K |
| 409 | ONCY | Oncolytics Biotech Inc. | 48.76M | -6.21% | 541,092 | - |
| 410 | ATNM | Actinium Pharmaceuticals, Inc. | 48.73M | 0.65% | 170,756 | 35.09M |
| 411 | PLRX | Pliant Therapeutics, Inc. | 48.65M | -1.74% | 360,284 | - |
| 412 | MREO | Mereo BioPharma Group plc | 47.70M | 1.22% | 1,752,917 | 800.00K |
| 413 | HOWL | Werewolf Therapeutics, Inc. | 47.22M | -3.80% | 216,237 | 21.00M |
| 414 | HYFT | MindWalk Holdings Corp. | 47.11M | -7.41% | 143,770 | 11.57M |
| 415 | GANX | Gain Therapeutics, Inc. | 46.70M | -1.83% | 411,640 | - |
| 416 | ELTX | Elicio Therapeutics, Inc. | 45.72M | -1.82% | 196,967 | - |
| 417 | DWTX | Dogwood Therapeutics, Inc. | 44.73M | -2.50% | 93,163 | 100.00K |
| 418 | CRBU | Caribou Biosciences, Inc. | 44.22M | -2.50% | 1,633,157 | 9.44M |
| 419 | TIL | Instil Bio, Inc. | 43.61M | -0.62% | 22,131 | - |
| 420 | KLRS | Kalaris Therapeutics, Inc. | 43.56M | -20.43% | 81,406 | - |
| 421 | CNTB | Connect Biopharma Holdings Limited | 43.11M | -8.76% | 409,708 | 2.95M |
| 422 | OSTX | OS Therapies Incorporated | 42.17M | -0.82% | 402,193 | - |
| 423 | IMA | ImageneBio, Inc. | 40.87M | -9.32% | 22,295 | 800.00K |
| 424 | ATHE | Alterity Therapeutics Limited | 40.79M | -3.70% | 16,190 | 2.50M |
| 425 | APLM | Apollomics, Inc. | 40.67M | 1.48% | 10,905 | 413.00K |
| 426 | TELO | Telomir Pharmaceuticals, Inc. | 40.49M | -20.29% | 431,567 | - |
| 427 | BMEA | Biomea Fusion, Inc. | 40.09M | -7.04% | 712,979 | - |
| 428 | GRDX | GridAI Technologies Corp. | 39.87M | 5.23% | 62,188 | - |
| 429 | HYPD | Hyperion DeFi, Inc. | 39.31M | -1.94% | 160,104 | 1.40M |
| 430 | IBO | Impact BioMedical Inc. | 39.30M | 6.24% | 9,085 | 38.00K |
| 431 | GRCE | Grace Therapeutics, Inc. | 38.92M | -0.80% | 27,959 | - |
| 432 | IRLA | IRulya Therapeutics Inc. | 38.65M | 12.51% | 166,103 | - |
| 433 | LONA | LeonaBio, Inc. | 38.06M | -9.62% | 85,556 | - |
| 434 | ALDX | Aldeyra Therapeutics, Inc. | 37.84M | -1.37% | 417,842 | - |
| 435 | SER | Serina Therapeutics, Inc. | 36.83M | 1.40% | 44,578 | 130.00K |
| 436 | NNVC | NanoViricides, Inc. | 36.50M | 7.52% | 203,179 | - |
| 437 | VERU | Veru Inc. | 35.81M | -4.11% | 128,438 | 16.89M |
| 438 | EXOZ | eXoZymes, Inc. | 35.73M | -9.94% | 18,286 | -700.00 |
| 439 | PMN | ProMIS Neurosciences, Inc. | 35.69M | -1.73% | 211,372 | - |
| 440 | EYPT | EyePoint, Inc. | 34.98M | 12.10% | 3,605,493 | 2.79M |
| 441 | PTHS | Pelthos Therapeutics Inc. | 34.46M | -3.95% | 42,710 | 43.30M |
| 442 | INMB | INmune Bio Inc. | 33.83M | -2.65% | 333,484 | 50.00K |
| 443 | ESLA | Estrella Immunopharma, Inc. | 33.00M | 47.64% | 3,853,015 | - |
| 444 | BCTX | BriaCell Therapeutics Corp. | 32.36M | 0.67% | 24,977 | - |
| 445 | ACET | Adicet Bio, Inc. | 32.29M | 0.33% | 382,728 | - |
| 446 | AARD | Aardvark Therapeutics, Inc. | 29.98M | 1.48% | 242,218 | - |
| 447 | LITS | Lite Strategy, Inc. | 29.14M | 0.94% | 273,214 | - |
| 448 | EDSA | Edesa Biotech, Inc. | 27.02M | -19.68% | 2,087,745 | - |
| 449 | NXTC | NextCure, Inc. | 26.69M | -7.02% | 81,122 | - |
| 450 | MGX | Metagenomi Therapeutics, Inc. | 26.66M | -2.20% | 168,799 | 13.56M |
| 451 | PLRZ | Polyrizon Ltd. | 26.54M | -1.09% | 3,846 | - |
| 452 | ABVC | ABVC BioPharma, Inc. | 25.96M | -1.97% | 32,036 | 797.92K |
| 453 | EVAX | Evaxion A/S | 24.94M | 8.73% | 92,213 | 7.49M |
| 454 | BYSI | BeyondSpring Inc. | 24.67M | -2.76% | 72,304 | 1.88M |
| 455 | CVM | CEL-SCI Corporation | 24.45M | 2.96% | 128,505 | - |
| 456 | FLNA | Filana Therapeutics, Inc. | 23.49M | -1.22% | 221,171 | - |
| 457 | CELU | Celularity Inc. | 23.03M | -6.57% | 97,675 | 18.67M |
| 458 | IMMP | Immutep Limited | 22.69M | -7.11% | 80,283 | 13.79M |
| 459 | RNAZ | TransCode Therapeutics, Inc. | 22.69M | -12.99% | 24,000 | - |
| 460 | ATOS | Atossa Therapeutics, Inc. | 21.46M | 0.94% | 55,406 | - |
| 461 | CRVO | CervoMed Inc. | 20.27M | -6.29% | 185,799 | 8.73K |
| 462 | IGC | IGC Pharma, Inc. | 20.19M | -4.45% | 203,728 | 1.11M |
| 463 | COCP | Cocrystal Pharma, Inc. | 19.84M | -6.79% | 33,048 | 330.00K |
| 464 | TVRD | Tvardi Therapeutics, Inc. | 19.21M | 2.13% | 545,015 | - |
| 465 | KTTA | Pasithea Therapeutics Corp. | 18.86M | 4.09% | 473,111 | - |
| 466 | BSEM | BioStem Technologies, Inc. | 18.77M | -9.82% | 432,620 | 34.59M |
| 467 | ATYR | aTyr Pharma, Inc. | 18.37M | -1.19% | 113,221 | 190.00K |
| 468 | QNRX | Quoin Pharmaceuticals, Ltd. | 17.92M | -4.48% | 6,255 | - |
| 469 | CNTX | Context Therapeutics Inc. | 17.37M | -5.59% | 721,502 | - |
| 470 | ALGS | Aligos Therapeutics, Inc. | 17.23M | -30.13% | 191,538 | 33.65M |
| 471 | BIVI | BioVie Inc. | 17.17M | -1.92% | 295,528 | - |
| 472 | QNTM | Quantum BioPharma Ltd. | 17.11M | -9.42% | 139,567 | - |
| 473 | AKTX | Akari Therapeutics, Plc | 17.00M | -2.87% | 26,989 | - |
| 474 | ABOS | Acumen Pharmaceuticals, Inc. | 16.85M | -1.69% | 1,767,712 | - |
| 475 | JSPR | Jasper Therapeutics, Inc. | 16.28M | -10.32% | 47,144 | - |
| 476 | BOLT | Bolt Biotherapeutics, Inc. | 16.24M | -2.33% | 111,662 | 4.70M |
| 477 | MCRB | Seres Therapeutics, Inc. | 16.07M | -5.88% | 38,172 | 2.13M |
| 478 | MRKR | Marker Therapeutics, Inc. | 16.06M | -2.76% | 53,041 | 3.55M |
| 479 | NCEL | NewcelX Ltd. | 16.06M | - | 24,095 | - |
| 480 | ACTU | Actuate Therapeutics, Inc. | 15.96M | -7.52% | 174,313 | - |
| 481 | KYNB | Kyntra Bio, Inc. | 15.31M | -3.08% | 100,324 | 4.62M |
| 482 | ALLR | Allarity Therapeutics, Inc. | 14.68M | -2.19% | 82,869 | 345.00K |
| 483 | NEUP | Neuphoria Therapeutics Inc. | 14.64M | -1.99% | 28,870 | 1.17M |
| 484 | DYAI | Dyadic International, Inc. | 14.21M | 2.50% | 60,916 | 3.80M |
| 485 | BCDA | BioCardia, Inc. | 14.08M | 3.06% | 36,843 | 3.00K |
| 486 | DARE | Daré Bioscience, Inc. | 13.62M | 1.87% | 160,678 | 1.37M |
| 487 | PLUR | Pluri Inc. | 13.46M | -7.63% | 16,168 | 1.02M |
| 488 | CTXR | Citius Pharmaceuticals, Inc. | 13.36M | -7.51% | 302,130 | 7.11M |
| 489 | LPCN | Lipocine Inc. | 13.19M | -6.98% | 157,939 | 3.74M |
| 490 | TCRX | TScan Therapeutics, Inc. | 12.48M | 1.38% | 580,508 | 7.11M |
| 491 | PASG | Passage Bio, Inc. | 12.26M | 11.08% | 29,604 | - |
| 492 | HIND | Vyome Holdings, Inc. | 11.55M | 3.46% | 4,885 | 129.73K |
| 493 | CLRB | Cellectar Biosciences, Inc. | 11.53M | -4.69% | 63,368 | - |
| 494 | PBM | Psyence Biomedical Ltd. | 11.37M | -1.32% | 26,098 | - |
| 495 | RADX | Radiopharm Theranostics Limited | 11.32M | -4.75% | 6,484 | 8.90M |
| 496 | GUTS | Fractyl Health, Inc. | 10.84M | -8.93% | 364,984 | 3.00K |
| 497 | PTN | Palatin Technologies, Inc. | 10.44M | -6.64% | 25,202 | 13.19M |
| 498 | MTVA | MetaVia Inc. | 10.28M | -3.11% | 102,208 | - |
| 499 | ICU | SeaStar Medical Holding Corporation | 10.07M | -2.30% | 36,193 | 1.71M |
| 500 | INTS | Intensity Therapeutics, Inc. | 10.02M | -2.54% | 8,653 | - |